Women can now assess their breast cancer risk with the help of AI
Everlywell will offer patients access to an AI tool approved by the FDA. The tool, called Clairity Breast, can predict a woman's five-year risk of breast cancer. It is based on imaging.
AI-generated summary
Read this story on The Seattle Times